Get the GWPH Research Report and
Also Receive Our Top Trades for 2017!

GW Pharmaceuticals Plc

On June 7, 2017, GW Pharmaceuticals plc (Nasdaq:GWPH), (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced that GW management will present at the Goldman Sachs 38th Annual Global Healthcare Conference on Wednesday, 14 June at 11:20 a.m. (PDT) at the Terranea Resort, Rancho Palos Verdes, CA. (See Research Report)
Download Research Report
on GWPH Now